Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C.

Source:http://linkedlifedata.com/resource/pubmed/id/21706207

Download in:

View as

General Info

PMID
21706207